Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome

Intensive Care Med. 2001 Jun;27(6):1103-4. doi: 10.1007/s001340100967.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Fatal Outcome
  • Hemodynamics / drug effects*
  • Hepatopulmonary Syndrome / drug therapy
  • Hepatopulmonary Syndrome / physiopathology*
  • Humans
  • Male
  • Methylene Blue / therapeutic use*
  • Middle Aged
  • Nitric Oxide / therapeutic use*
  • Vasodilator Agents / therapeutic use*

Substances

  • Vasodilator Agents
  • Nitric Oxide
  • Methylene Blue